- Home
- FGEN vs SURG Comparison
FGEN vs SURG Comparison
Compare FGEN & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- SURG
- Stock Information
- Founded
- FGEN 1993
- SURG 2006
- Country
- FGEN United States
- SURG United States
- Employees
- FGEN N/A
- SURG N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- SURG Advertising
- Sector
- FGEN Health Care
- SURG Consumer Discretionary
- Exchange
- FGEN Nasdaq
- SURG Nasdaq
- Market Cap
- FGEN 34.5M
- SURG 35.9M
- IPO Year
- FGEN 2014
- SURG N/A
- Fundamental
- Price
- FGEN $0.57
- SURG $1.55
- Analyst Decision
- FGEN
- SURG Buy
- Analyst Count
- FGEN 0
- SURG 2
- Target Price
- FGEN N/A
- SURG $8.50
- AVG Volume (30 Days)
- FGEN 1.7M
- SURG 202.3K
- Earning Date
- FGEN 02-24-2025
- SURG 03-11-2025
- Dividend Yield
- FGEN N/A
- SURG N/A
- EPS Growth
- FGEN N/A
- SURG N/A
- EPS
- FGEN N/A
- SURG N/A
- Revenue
- FGEN $180,015,000.00
- SURG $83,602,653.00
- Revenue This Year
- FGEN $22.05
- SURG N/A
- Revenue Next Year
- FGEN N/A
- SURG $59.69
- P/E Ratio
- FGEN N/A
- SURG N/A
- Revenue Growth
- FGEN 16.15
- SURG N/A
- 52 Week Low
- FGEN $0.18
- SURG $1.33
- 52 Week High
- FGEN $2.93
- SURG $9.23
- Technical
- Relative Strength Index (RSI)
- FGEN 57.36
- SURG 36.60
- Support Level
- FGEN $0.51
- SURG $1.74
- Resistance Level
- FGEN $0.76
- SURG $1.75
- Average True Range (ATR)
- FGEN 0.09
- SURG 0.10
- MACD
- FGEN -0.00
- SURG -0.02
- Stochastic Oscillator
- FGEN 33.26
- SURG 0.00
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.